Trials / Terminated
TerminatedNCT02475187
Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (estimated)
- Sponsor
- Vestre Viken Hospital Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Measurement of thrombogenic properties by TEG and MEA and observation of thrombotic events over 2 years in 220 patients with hip fracture.
Detailed description
Patients with proximal femur fracture have high incidences of thrombotic events. By the two "bed-side" methods TEG (Thrombelastography) and MEA (Multiple Electrode Aggregometry), the thrombogenic properties of 220 patients with proximal femur fracture will be measured at time of hospital admission and 4 times over a period of 6 months postoperatively, and the patients will be followed in a total length of 2 years to register thrombotic events.
Conditions
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2018-02-01
- Completion
- 2018-02-01
- First posted
- 2015-06-18
- Last updated
- 2021-04-15
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT02475187. Inclusion in this directory is not an endorsement.